Literature DB >> 28509623

Gastrostomy in patients with prion disease.

Yasushi Iwasaki1, Keiko Mori2, Masumi Ito2, Yoshinari Kawai2, Ken-Ichiro Hoshino3, Yuko Kawabata4, Maya Mimuro1, Mari Yoshida1.   

Abstract

Patients with prion diseases can live for long periods of time in a state of akinetic mutism given appropriate management of their symptoms. To study symptom support in these cases, we performed gastrostomies on 3 patients with V180I genetic Creutzfeldt-Jakob disease (CJD) who had become akinetic and mute, and compared them to 14 other similar patients being fed by tube. In the 3 gastrostomy cases, there were no direct complications due to the gastrostomy or tube feeding, nor were there episodes of discontinuation of tube feeding or initiation of continuous drip infusion due to severe complications. Antibiotics were administered for mild infections, a complication of CJD, with 0.2% and 8.8% of the total time after gastrostomy being used for intravenous or transluminal administration, respectively. We compared the present patient series with that of our previous report statistically, and found that patients undergoing gastrostomy required significantly fewer discontinuations of tube feeding than those who did not. No significant difference in antibiotic administration was found between groups, however. It is our conclusion that gastrostomy should be allowed for symptom support in akinetic patients with prion disease, but adequate informed consent must be provided to the patient's family.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; akinetic mutism state; codon 180; gastrostomy; prion disease; symptomatic treatment; tube feeding

Mesh:

Substances:

Year:  2017        PMID: 28509623      PMCID: PMC5480383          DOI: 10.1080/19336896.2017.1306164

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  9 in total

1.  Survival to akinetic mutism state in Japanese cases of MM1-type sporadic Creutzfeldt-Jakob disease is similar to Caucasians.

Authors:  Y Iwasaki; M Mimuro; M Yoshida; T Kitamoto; Y Hashizume
Journal:  Eur J Neurol       Date:  2010-08-16       Impact factor: 6.089

2.  Clinicopathologic characteristics of sporadic Japanese Creutzfeldt-Jakob disease classified according to prion protein gene polymorphism and prion protein type.

Authors:  Yasushi Iwasaki; Mari Yoshida; Yoshio Hashizume; Tetsuyuki Kitamoto; Gen Sobue
Journal:  Acta Neuropathol       Date:  2006-07-18       Impact factor: 17.088

Review 3.  Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances.

Authors:  Claudio A R Gomes; Régis B Andriolo; Cathy Bennett; Suzana A S Lustosa; Delcio Matos; Daniel R Waisberg; Jaques Waisberg
Journal:  Cochrane Database Syst Rev       Date:  2015-05-22

4.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

5.  Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Yasushi Iwasaki; Akio Akagi; Maya Mimuro; Tetsuyuki Kitamoto; Mari Yoshida
Journal:  J Neurol Sci       Date:  2015-06-30       Impact factor: 3.181

6.  An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Masamitsu Nagaoka; Toshiaki Ieda; Tetsuyuki Kitamoto; Mari Yoshida; Yoshio Hashizume
Journal:  Neuropathology       Date:  2011-01-27       Impact factor: 1.906

7.  [Investigation of the clinical course and treatment of prion disease patients in the akinetic mutism state in Japan].

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito
Journal:  Rinsho Shinkeigaku       Date:  2012

8.  Prospective 10-year surveillance of human prion diseases in Japan.

Authors:  Ichiro Nozaki; Tsuyoshi Hamaguchi; Nobuo Sanjo; Moeko Noguchi-Shinohara; Kenji Sakai; Yosikazu Nakamura; Takeshi Sato; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Fumio Moriwaka; Yusei Shiga; Yoshiyuki Kuroiwa; Masatoyo Nishizawa; Shigeki Kuzuhara; Takashi Inuzuka; Masatoshi Takeda; Shigetoshi Kuroda; Koji Abe; Hiroyuki Murai; Shigeo Murayama; Jun Tateishi; Ichiro Takumi; Susumu Shirabe; Masafumi Harada; Atsuko Sadakane; Masahito Yamada
Journal:  Brain       Date:  2010-09-20       Impact factor: 13.501

9.  Three cases of Creutzfeldt-Jakob disease with prion protein gene codon180 mutation presenting with pathological laughing and crying.

Authors:  Yasushi Iwasaki
Journal:  J Neurol Sci       Date:  2012-05-31       Impact factor: 3.181

  9 in total
  4 in total

1.  Serial evaluation of swallowing function in a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.

Authors:  Kenjiro Kunieda; Yuichi Hayashi; Megumi Yamada; Masahiro Waza; Tomonori Yaguchi; Ichiro Fujishima; Takayoshi Shimohata
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

2.  Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System.

Authors:  Katsuya Satoh; Takayuki Fuse; Toshiaki Nonaka; Trong Dong; Masaki Takao; Takehiro Nakagaki; Daisuke Ishibashi; Yuzuru Taguchi; Ban Mihara; Yasushi Iwasaki; Mari Yoshida; Noriyuki Nishida
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

3.  Enteral feeding is associated with longer survival in the advanced stages of prion disease.

Authors:  Kirsty McNiven; Akin Nihat; Tze How Mok; Selam Tesfamichael; Veronica O'Donnell; Peter Rudge; John Collinge; Simon Mead
Journal:  Brain Commun       Date:  2019-09-10

4.  System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Akio Akagi; Yuichi Riku; Hiroaki Miyahara; Atsushi Kobayashi; Tetsuyuki Kitamoto; Mari Yoshida
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.